174
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Risk of Breast Cancer and Changes in Mammographic Parenchymal Patterns Over Time

, , &
Pages 547-551 | Published online: 08 Jul 2009

References

  • Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976; 126: 1130–9.
  • Wolfe JN. Risk for breast cancer development determined by mammography parenchymal pattern. Cancer 1976; 37: 2486–92.
  • de Stavola BL, Gravelle IH, Wang DY, et al. Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol 1990; 19: 247–54.
  • Warner E, Lockwood G, Tritchel D, Boyd NF. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to exam-ine the effect of method of classification. Cancer Detect Prey 1992; 16: 67–72.
  • Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo P. A nested case-control study of mammographic patterns, breast volume and breast cancer. Cancer Causes Control 1995; 6: 431 —8.
  • Ciatto S, Zappa M. A prospective study of the value of mammographic patterns as indicators of breast cancer risk in a screening experience. Eur J Radiol 1993; 17: 122–5.
  • Kalisher L, McLelland R. The role of mammographic par-enchymal patterns in screening for carcinoma of the breast. Gynecol Obstet 1991; 172: 81–8.
  • Hakama M, Pukkala E, Kallio M, Godenhjelm K, Svin-hufvud U. Effectiveness of screening for breast cancer in women under 50 years at entry: the Kotka pilot project in Finland. Int .1- Cancer 1995; 63: 55–7.
  • Salminen T, Hakama M, Heikkild M, Saarenmaa I. Fa-vourable change in mammographic parenchymal patterns and breast cancer risk factors. Int .1- Cancer 1998 (In Press).
  • Cox DR, Oakes D. Analysis of survival data. London, New York: Chapman and Hall, 1984.
  • Saftlas AF, Szklo M. Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev 1987; 9: 146–74.
  • Boyd NF, O'Sullivan B, Fishell E, Simor I, Cooke G. Mam-mographic patterns and breast cancer risk: methodologic standards and contradictory results. J Natl Cancer Inst 1984; 72: 1253–9.
  • Saftlas AF, Wolfe JN, Hoover RN, et al. Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol 1989; 129: 518–26.
  • Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995; 87: 1622–9.
  • Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993; 15: 196–208.
  • Carlile T, Kopecky KJ, Thompson DJ, et al. Breast cancer prediction and the Wolfe classification of mammograms. JAMA 1985; 254: 1050–3.
  • Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and the breast cancer risk. Am J Epidemiol 1989; 130: 14–24.
  • Soini I, Hakama M. Failure of selective screening for breast cancer by combining risk factors. Int J Cancer 1978; 22: 275–81.
  • Farewell VT. The combined effect of breast cancer risk fac-tors. Cancer 1977; 40: 931–6.
  • de Waard F, Rombach JJ, Collette HJA. The DOM-project for the early diagnosis of breast cancer in the city of Utrecht, the Netherlands. In: Miller AB, ed. Screening in cancer. Geneva: UICC Technical Report Series, 1978: 183–200.
  • McDermott F. Risk factors in breast cancer. Aust Fam Physician 1991; 20: 1455–60.
  • Ciatto S, Bravetti P, Cecchini S, Cirillo A. Mammographic parenchymal patterns and breast cancer risk. A case control study of a population-based screening experience. Radiol Med 1990; 79: 346–8.
  • Tabar K, Dean PB. Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA 1982; 247: 185–9.
  • Joensuu H, Asola R, Holli K, Kumpulainen E, Nikkanen V, Parvinen L-M. Delayed diagnosis and large size of breast cancer after a false negative mammogram. Eur J Cancer 1994; 30A: 1299–302.
  • Hakama M, Elovainio L, Kajantie R, Louhivuori K. Breast cancer screening as a public health policy in Finland. Br J Cancer 1991; 64: 962–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.